Literature DB >> 22480762

Prior contralateral amputation predicts worse outcomes for lower extremity bypasses performed in the intact limb.

Donald T Baril1, Philip P Goodney, William P Robinson, Brian W Nolan, David H Stone, YouFu Li, Jack L Cronenwett, Andres Schanzer.   

Abstract

INTRODUCTION: To date, history of a contralateral amputation as a potential predictor of outcomes after lower extremity bypass (LEB) for critical limb ischemia (CLI) has not been studied. We sought to determine if a prior contralateral lower extremity amputation predicts worse outcomes in patients undergoing LEB in the remaining intact limb.
METHODS: A retrospective analysis of all patients undergoing infrainguinal LEB for CLI between 2003 and 2010 within hospitals comprising the Vascular Study Group of New England was performed. Patients were stratified according to whether or not they had previously undergone a contralateral major or minor amputation before LEB. Primary end points included major amputation and graft occlusion at 1 year postoperatively. Secondary end points included in-hospital major adverse events, discharge status, and mortality at 1 year.
RESULTS: Of 2636 LEB procedures, 228 (8.6%) were performed in the setting of a prior contralateral amputation. Patients with a prior amputation compared to those without were younger (66.5 vs 68.7; P = .034), more like to have congestive heart failure (CHF; 25% vs 16%; P = .002), hypertension (94% vs 85%; P = .015), renal insufficiency (26% vs 14%; P = .0002), and hemodialysis-dependent renal failure (14% vs 6%; P = .0002). They were also more likely to be nursing home residents (8.0% vs 3.6%; P = .036), less likely to ambulate without assistance (41% vs 80%; P < .0002), and more likely to have had a prior ipsilateral bypass (20% vs 12%; P = .0005). These patients experience increased in-hospital major adverse events, including myocardial infarction (MI; 8.9% vs 4.2%; P = .002), CHF (6.1% vs 3.4%; P = .044), deterioration in renal function (9.0% vs 4.7%; P = .006), and respiratory complications (4.2% vs 2.3%; P = .034). They were less likely to be discharged home (52% vs 72%; P < .0001) and less likely to be ambulatory on discharge (25% vs 55%; P < .0001). Although patients with a prior contralateral amputation experienced increased rates of graft occlusion (38% vs 17%; P < .0001) and major amputation (16% vs 7%; P < .0001) at 1 year, there was not a significant difference in mortality (16% vs 10%; P = .160). On multivariable analysis, prior contralateral amputation was an independent predictor of both major amputation (odds ratio, 1.73; confidence interval, 1.06-2.83; P = .027) and graft occlusion (odds ratio, 1.93; confidence interval, 1.39-2.68; P < .0001) at 1 year.
CONCLUSIONS: Patients with prior contralateral amputations who present with CLI in the intact limb represent a high-risk population, even among patients with advanced peripheral arterial disease. When considering LEB in this setting, both physicians and patients should expect increased rates of perioperative adverse events, increased rates of 1-year graft occlusion, and decreased rates of limb salvage, when compared with patients who have not undergone a contralateral amputation.
Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22480762      PMCID: PMC3766714          DOI: 10.1016/j.jvs.2012.01.041

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  21 in total

1.  Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.

Authors:  Michael S Conte; Dennis F Bandyk; Alexander W Clowes; Gregory L Moneta; Hamid Namini; Lynn Seely
Journal:  J Vasc Surg       Date:  2005-09       Impact factor: 4.268

2.  Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass.

Authors:  Brian W Nolan; Randall R De Martino; David H Stone; Andres Schanzer; Philip P Goodney; Daniel W Walsh; Jack L Cronenwett
Journal:  J Vasc Surg       Date:  2011-07-29       Impact factor: 4.268

3.  A decade experience with infrainguinal revascularization in a dialysis-dependent patient population.

Authors:  Pranay Ramdev; Sunil S Rayan; Malachi Sheahan; Allen D Hamdan; Frank W Logerfo; Cameron M Akbari; David R Campbell; Frank B Pomposelli
Journal:  J Vasc Surg       Date:  2002-11       Impact factor: 4.268

4.  Potential predictors of outcome in patients with tissue loss who undergo infrainguinal vein bypass grafting.

Authors:  J M Seeger; H A Pretus; L C Carlton; T C Flynn; C K Ozaki; T S Huber
Journal:  J Vasc Surg       Date:  1999-09       Impact factor: 4.268

5.  Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial.

Authors:  Andres Schanzer; Nathanael Hevelone; Christopher D Owens; Michael Belkin; Dennis F Bandyk; Alexander W Clowes; Gregory L Moneta; Michael S Conte
Journal:  J Vasc Surg       Date:  2007-12       Impact factor: 4.268

6.  A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE).

Authors:  Jack L Cronenwett; Donald S Likosky; Margaret T Russell; Jens Eldrup-Jorgensen; Andrew C Stanley; Brian W Nolan
Journal:  J Vasc Surg       Date:  2007-10-24       Impact factor: 4.268

7.  Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia.

Authors:  Jyrki Virkkunen; Maarit Heikkinen; Mauri Lepäntalo; Riina Metsänoja; Juha-Pekka Salenius
Journal:  J Vasc Surg       Date:  2004-10       Impact factor: 4.268

8.  Fate of the contralateral leg after infrainguinal bypass.

Authors:  W C Tarry; D B Walsh; N J Birkmeyer; M F Fillinger; R M Zwolak; J L Cronenwett
Journal:  J Vasc Surg       Date:  1998-06       Impact factor: 4.268

9.  Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.

Authors:  Andres Schanzer; Jessica Mega; Judith Meadows; Russell H Samson; Dennis F Bandyk; Michael S Conte
Journal:  J Vasc Surg       Date:  2008-12       Impact factor: 4.268

10.  Incidence of lower-limb amputation in the diabetic and nondiabetic general population: a 10-year population-based cohort study of initial unilateral and contralateral amputations and reamputations.

Authors:  Anton Johannesson; Gert-Uno Larsson; Nerrolyn Ramstrand; Aleksandra Turkiewicz; Ann-Britt Wiréhn; Isam Atroshi
Journal:  Diabetes Care       Date:  2008-11-10       Impact factor: 19.112

View more
  1 in total

1.  Cost-effectiveness of revascularization for limb preservation in patients with end-stage renal disease.

Authors:  Neal R Barshes; Panos Kougias; C Keith Ozaki; Philip P Goodney; Michael Belkin
Journal:  J Vasc Surg       Date:  2014-03-20       Impact factor: 4.268

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.